Dr. Reddy's Laboratories intimates a board meeting to consider recommending a final dividend for FY 2025-26.
The meeting is scheduled following a prior intimation dated March 23, 2026.
The disclosure is made under SEBI Listing Regulations, specifically Regulation 29.